Preventive thinking - A contradiction to individualised doctoring

European Journal of General Practice

Volumn 9, Issue 4, 2003, Pages 148-150

  Abholz, Heinz Harald ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

CANCER SURGERY; CORONARY ARTERY ATHEROSCLEROSIS; CULTURAL FACTOR; DEPRESSION; ESOPHAGITIS; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE; HEALTH CARE NEED; HEALTH PROGRAM; HELICOBACTER INFECTION; HUMAN; HYGIENE; IMMUNIZATION; IMPAIRED GLUCOSE TOLERANCE; INDIVIDUALIZATION; INFECTION; INTESTINE POLYP; ISCHEMIC HEART DISEASE; LEUKOPLAKIA; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL SPECIALIST; PATIENT CARE; PATIENT COUNSELING; PATIENT REFERRAL; PRACTICE GUIDELINE; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; STATISTICAL ANALYSIS; SUNBURN; SYMPTOMATOLOGY; THINKING; TREATMENT OUTCOME; ULCER;

EID: 0347664019     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.3109/13814780309160426     Document Type: Review

References (11)

1. Rose G. The Strategy of Preventive Medicine. Oxford University Press: 1992.
2. Misselbrook D, Armstrong D. Patients' response to risk information about benefits of treating hypertension. Br J Gen Pract 2001;51:276-9.
3. Walter FM, Britten N. Patients' understanding of risk: A qualitative study of decision making about the menopause and hormone replacement therapy in general practice. Fam Pract 2002;19:579-86.
4. Fitzpatrick M. The Tyranny of Health. London: Routledge, 2001.
5. Greenhalgh T. Intuition and evidence - Uneasy bedfellows? Br J Gen Pract 2002;52:395-400.
6. Bradley GW. Disease, Diagnosis and Decisions. Wiley, Chichester 1993; Chapter 3.
7. Fraser RC. Clinical Method - A General Practice Approach. London: Butterworth, 1987.
8. Stewart M, Brown JB, Weston WW, et al. Patient-Centred Medicine - Transforming the Clinical Method. Thousand Oaks, Call./US: Sage, 1995. [Especially in chapters 2 and 3.]
9. Echt DS, Liebson PR, Mitchel LB, et al. Morbidity and mortality in patients receiving encainide, flecainide, or placebo. N Engl J Med 1991;324:781-8.
10. Campbell N, Murchie P. The international perspective of structured disease management programmes for secondary prevention in coronary heart disease. in: Grundlagen Einer Evidenz-Basierten Ambulanten Versorgung von KHK-Patienten. Essen: Medizin Dienst der Spitzenverbände, 2003.
11. Berg M. Rationalizing Medical Work. Cambridge (MA): MIT Press, 1997.